BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hayek G, Ronot M, Plessier A, Sibert A, Abdel-Rehim M, Zappa M, Rautou PE, Valla D, Vilgrain V. Long-term Outcome and Analysis of Dysfunction of Transjugular Intrahepatic Portosystemic Shunt Placement in Chronic Primary Budd-Chiari Syndrome. Radiology. 2017;283:280-292. [PMID: 27797679 DOI: 10.1148/radiol.2016152641] [Cited by in Crossref: 33] [Cited by in F6Publishing: 22] [Article Influence: 5.5] [Reference Citation Analysis]
Number Citing Articles
1 Tripathi D, Stanley AJ, Hayes PC, Travis S, Armstrong MJ, Tsochatzis EA, Rowe IA, Roslund N, Ireland H, Lomax M, Leithead JA, Mehrzad H, Aspinall RJ, McDonagh J, Patch D. Transjugular intrahepatic portosystemic stent-shunt in the management of portal hypertension. Gut 2020;69:1173-92. [PMID: 32114503 DOI: 10.1136/gutjnl-2019-320221] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 11.0] [Reference Citation Analysis]
2 Hernández-Gea V, De Gottardi A, Leebeek FWG, Rautou PE, Salem R, Garcia-Pagan JC. Current knowledge in pathophysiology and management of Budd-Chiari syndrome and non-cirrhotic non-tumoral splanchnic vein thrombosis. J Hepatol 2019;71:175-99. [PMID: 30822449 DOI: 10.1016/j.jhep.2019.02.015] [Cited by in Crossref: 31] [Cited by in F6Publishing: 22] [Article Influence: 10.3] [Reference Citation Analysis]
3 Chen ZK, Fan J, Cao C, Li Y. Endovascular treatment for hepatic vein-type Budd-Chiari syndrome: effectiveness and long-term outcome. Radiol Med 2018;123:799-807. [PMID: 29856000 DOI: 10.1007/s11547-018-0907-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Wan YM, Li YH, Xu ZY, Wu HM, Wu XN, Xu Y, Guo T. Transjugular Intrahepatic Portosystemic Shunt:The Impact of Portal Venous Pressure Declines on Shunt Patency and Clinical Efficacy. Acad Radiol 2019;26:188-95. [PMID: 29934023 DOI: 10.1016/j.acra.2018.05.015] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
5 Sharma A, Keshava SN, Eapen A, Elias E, Eapen CE. An Update on the Management of Budd-Chiari Syndrome. Dig Dis Sci 2021;66:1780-90. [PMID: 32691382 DOI: 10.1007/s10620-020-06485-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
6 Madhusudhan KS, Sharma S. Ultrasonography in pediatric Budd-Chiari syndrome. Pediatr Radiol 2020;50:1768-80. [PMID: 32870359 DOI: 10.1007/s00247-020-04753-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
7 Wang L, Wang R, Zhang C, Yue Z, Zhao H, Fan Z, Wu Y, Zhang Y, Liu F, Dong J. Hepatic parenchyma and vascular blood flow changes after TIPS with spectral CT iodine density in HBV-related liver cirrhosis. Sci Rep 2021;11:10535. [PMID: 34006977 DOI: 10.1038/s41598-021-89764-6] [Reference Citation Analysis]
8 Inchingolo R, Posa A, Mariappan M, Tibana TK, Nunes TF, Spiliopoulos S, Brountzos E. Transjugular intrahepatic portosystemic shunt for Budd-Chiari syndrome: A comprehensive review. World J Gastroenterol 2020; 26(34): 5060-5073 [PMID: 32982109 DOI: 10.3748/wjg.v26.i34.5060] [Cited by in CrossRef: 2] [Article Influence: 1.0] [Reference Citation Analysis]
9 Zanetto A, Barbiero G, Battistel M, Sciarrone SS, Shalaby S, Pellone M, Battistella S, Gambato M, Germani G, Russo FP, Burra P, Senzolo M. Management of portal hypertension severe complications. Minerva Gastroenterol (Torino) 2021;67:26-37. [PMID: 33140623 DOI: 10.23736/S2724-5985.20.02784-1] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
10 Khan F, Mehrzad H, Tripathi D. Timing of Transjugular Intrahepatic Portosystemic Stent-shunt in Budd-Chiari Syndrome: A UK Hepatologist's Perspective. J Transl Int Med. 2018;6:97-104. [PMID: 30425945 DOI: 10.2478/jtim-2018-0022] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
11 Shukla A, Shreshtha A, Mukund A, Bihari C, Eapen CE, Han G, Deshmukh H, Cua IHY, Lesmana CRA, Al Meshtab M, Kage M, Chaiteeraki R, Treeprasertsuk S, Giri S, Punamiya S, Paradis V, Qi X, Sugawara Y, Abbas Z, Sarin SK. Budd-Chiari syndrome: consensus guidance of the Asian Pacific Association for the study of the liver (APASL). Hepatol Int 2021;15:531-67. [PMID: 34240318 DOI: 10.1007/s12072-021-10189-4] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Rautou PE, Elkrief L, Decraecker M, Ollivier-Hourmand I, Plessier A, Ronot M, Vilgrain V, Bourlière M, Ganne-Carrié N, de Lédinghen V, Bureau C. NON-INVASIVE DIAGNOSIS AND FOLLOW-UP OF VASCULAR LIVER DISEASES. Clin Res Hepatol Gastroenterol 2021;:101764. [PMID: 34332130 DOI: 10.1016/j.clinre.2021.101764] [Reference Citation Analysis]
13 Khan F, Armstrong MJ, Mehrzad H, Chen F, Neil D, Brown R, Cain O, Tripathi D. Review article: a multidisciplinary approach to the diagnosis and management of Budd-Chiari syndrome. Aliment Pharmacol Ther. 2019;49:840-863. [PMID: 30828850 DOI: 10.1111/apt.15149] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
14 Shalimar, Gamanagatti SR, Patel AH, Kedia S, Nayak B, Gunjan D, Ranjan G, Paul SB, Acharya SK. Long-term outcomes of transjugular intrahepatic portosystemic shunt in Indian patients with Budd-Chiari syndrome. Eur J Gastroenterol Hepatol. 2017;29:1174-1182. [PMID: 28763339 DOI: 10.1097/meg.0000000000000945] [Cited by in Crossref: 14] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
15 Abou-Ismail MY, Prchal JT, Deininger MW, Parker CJ, Lim MY. Anticoagulation management post-transjugular intrahepatic portosystemic shunt in portal hypertension associated with myeloproliferative neoplasms. Blood Coagul Fibrinolysis 2021;32:578-83. [PMID: 34608880 DOI: 10.1097/MBC.0000000000001087] [Reference Citation Analysis]
16 Stirnimann G, Berg T, Spahr L, Zeuzem S, McPherson S, Lammert F, Storni F, Banz V, Babatz J, Vargas V, Geier A, Stallmach A, Engelmann C, Trepte C, Capel J, De Gottardi A. Treatment of refractory ascites with an automated low-flow ascites pump in patients with cirrhosis. Aliment Pharmacol Ther. 2017;46:981-991. [PMID: 28940225 DOI: 10.1111/apt.14331] [Cited by in Crossref: 30] [Cited by in F6Publishing: 20] [Article Influence: 6.0] [Reference Citation Analysis]
17 Wang Q, Han G. Image-guided treatment of Budd-Chiari syndrome: a giant leap from the past, a small step towards the future. Abdom Radiol 2018;43:1908-19. [DOI: 10.1007/s00261-017-1341-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
18 Li H, Zhang X, Xu H, Zu M, Wei N, Liu H, Xiao J, Shen B, Huang Q, Zhang Q. Long-term outcomes of interventional treatment for Budd-Chiari syndrome with chronic accessory hepatic vein obstruction. Eur J Gastroenterol Hepatol 2021;33:709-16. [PMID: 32483089 DOI: 10.1097/MEG.0000000000001784] [Reference Citation Analysis]
19 Li YH, Xu ZY, Wu HM, Yang LH, Xu Y, Wu XN, Wan YM. Long-term shunt patency and overall survival of transjugular intrahepatic portosystemic shunt placement using covered stents with bare stents versus covered stents alone. Clin Radiol. 2018;73:580-587. [PMID: 29475551 DOI: 10.1016/j.crad.2018.01.014] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.8] [Reference Citation Analysis]
20 Haque LYK, Lim JK. Budd-Chiari Syndrome: An Uncommon Cause of Chronic Liver Disease that Cannot Be Missed. Clin Liver Dis 2020;24:453-81. [PMID: 32620283 DOI: 10.1016/j.cld.2020.04.012] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
21 Li DM, Yin X, Yang F, Zhang LG, Liu TG, Fu YF. Accessory hepatic vein recanalization for hepatic vein-type Budd-Chiari syndrome. Minim Invasive Ther Allied Technol 2021;30:239-44. [PMID: 32022611 DOI: 10.1080/13645706.2020.1723110] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
22 Sakr M, Abdelhakam SM, Elsayed SA, Allam EH, Farid AM, Abdelmoaty W, Hassan AM, Shaker M, El-Gharib M, Eldorry A. Validation of prognostic indices in Egyptian Budd-Chiari syndrome patients: A single-center study. World J Gastroenterol 2017; 23(4): 629-637 [PMID: 28216969 DOI: 10.3748/wjg.v23.i4.629] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.4] [Reference Citation Analysis]
23 Oey RC, de Wit K, Moelker A, Atalik T, van Delden OM, Maleux G, Erler NS, Takkenberg RB, de Man RA, Nevens F, van Buuren HR. Variable efficacy of TIPSS in the management of ectopic variceal bleeding: a multicentre retrospective study. Aliment Pharmacol Ther 2018;48:975-83. [PMID: 30136292 DOI: 10.1111/apt.14947] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
24 Wan YM, Li YH, Xu Y, Wu HM, Li YC, Wu XN, Yang JH. Predictors of Shunt Dysfunction and Overall Survival in Patients with Variceal Bleeding Treated with Transjugular Portosystemic Shunt Creation Using the Fluency Stent Graft. Acad Radiol 2018;25:925-34. [PMID: 29373208 DOI: 10.1016/j.acra.2017.11.020] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
25 Reilly CR, Babushok DV, Martin K, Spivak JL, Streiff M, Bahirwani R, Mondschein J, Stein B, Moliterno A, Hexner EO. Multicenter analysis of the use of transjugular intrahepatic portosystemic shunt for management of MPN-associated portal hypertension. Am J Hematol 2017;92:909-14. [PMID: 28543980 DOI: 10.1002/ajh.24798] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
26 Coilly A, Potier P, Broué P, Kounis I, Valla D, Hillaire S, Lambert V, Dutheil D, Hernández-gea V, Plessier A, Vilgrain V, Bureau C. Budd-Chiari syndrome. Clinics and Research in Hepatology and Gastroenterology 2020;44:420-5. [DOI: 10.1016/j.clinre.2020.03.015] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
27 Cannataci C, Cimo' B, Mamone G, Tuzzolino F, D'Amico M, Cortis K, Maruzzelli L, Miraglia R. Portal vein puncture-related complications during transjugular intrahepatic portosystemic shunt creation: Colapinto needle set vs Rösch-Uchida needle set. Radiol Med 2021;126:1487-95. [PMID: 34405340 DOI: 10.1007/s11547-021-01404-1] [Reference Citation Analysis]
28 Simonetto DA, Singal AK, Garcia-Tsao G, Caldwell SH, Ahn J, Kamath PS. ACG Clinical Guideline: Disorders of the Hepatic and Mesenteric Circulation. Am J Gastroenterol. 2020;115:18-40. [PMID: 31895720 DOI: 10.14309/ajg.0000000000000486] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 13.0] [Reference Citation Analysis]